Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery

Clinical trial NCT03113825 · COMPLETED

Trial details

NCT number: NCT03113825
Sponsor: Avelas Biosciences, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Primary Invasive Malignant Neoplasm of Female Breast Carcinoma Breast Breast Cancer Female Carcinoma, Ductal, Breast Stage II Breast Cancer Stage I Breast Cancer Stage III Breast Cancer

Start date: 2017-07-05
Primary completion: 2020-04-08
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.